Australia
· Delayed Price · Currency is AUD Imricor Medical Systems Statistics
Total Valuation
ASX:IMR has a market cap or net worth of AUD 398.75 million. The enterprise value is 407.65 million.
| Market Cap | 398.75M |
| Enterprise Value | 407.65M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:IMR has 270.34 million shares outstanding. The number of shares has increased by 43.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 270.34M |
| Shares Change (YoY) | +43.03% |
| Shares Change (QoQ) | +34.96% |
| Owned by Insiders (%) | 8.65% |
| Owned by Institutions (%) | 11.13% |
| Float | 222.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 213.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.50 |
| EV / Sales | 262.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.12 |
Financial Position
The company has a current ratio of 7.79
| Current Ratio | 7.79 |
| Quick Ratio | 6.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -812.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.06% |
| Return on Invested Capital (ROIC) | -128.95% |
| Return on Capital Employed (ROCE) | -84.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +170.64% in the last 52 weeks. The beta is 0.32, so ASX:IMR's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +170.64% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 0.91 |
| Relative Strength Index (RSI) | 50.69 |
| Average Volume (20 Days) | 352,288 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IMR had revenue of AUD 1.55 million and -47.98 million in losses. Loss per share was -0.21.
| Revenue | 1.55M |
| Gross Profit | -1.49M |
| Operating Income | -26.33M |
| Pretax Income | -47.98M |
| Net Income | -47.98M |
| EBITDA | -25.13M |
| EBIT | -26.33M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 25.38 million in cash and 34.28 million in debt, giving a net cash position of -8.90 million or -0.03 per share.
| Cash & Cash Equivalents | 25.38M |
| Total Debt | 34.28M |
| Net Cash | -8.90M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -11.92M |
| Book Value Per Share | -0.04 |
| Working Capital | 25.84M |
Cash Flow
In the last 12 months, operating cash flow was -25.17 million and capital expenditures -126,001, giving a free cash flow of -25.29 million.
| Operating Cash Flow | -25.17M |
| Capital Expenditures | -126,001 |
| Free Cash Flow | -25.29M |
| FCF Per Share | -0.09 |
Margins
| Gross Margin | -96.32% |
| Operating Margin | -1,698.60% |
| Pretax Margin | -3,094.86% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:IMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.03% |
| Shareholder Yield | -43.03% |
| Earnings Yield | -12.03% |
| FCF Yield | -6.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:IMR has an Altman Z-Score of -8.86. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.86 |
| Piotroski F-Score | n/a |